In my experience at large pharma and biotech startups, Tager&Co. stands out as a valued, strategic resource that is remarkably productive. They’ve helped us build an effective communication strategy for our various stakeholders. It is a pleasure working with such talent.” 

The past 18 months have been transformational, including the way we communicate. While the media has been covering the COVID pandemic, getting them to consider any story outside their focus needs a new approach, persistence, an extensive and reliable network and trust. Tager&Co. has all these attributes as well as a strategic approach to getting traction with media outlets."

Dave and his team’s media results — the 60 Minutes profile, regular stories in the New York Times and Wall Street Journal, interviews on CNBC and with other top outlets — have been major contributors to Year Up’s growth and success. … Beyond PR, Tager’s connections to senior executives at companies such as US Bank and Citadel have led to enduring, valuable corporate partnerships.”

We hired Tager&Co. to help promote Brain Chemistry Labs’ milestone achievements for Alzheimer’s and ALS research. Their outstanding PR initiatives yielded us tremendous press coverage, including a 12-page cover story in Fortune magazine. A feature story like this is … a game-changer that will help attract substantial financial support.”

When Crown Global wanted to build its institutional business, we turned to Tager&Co. … They helped develop a bylined article, got it published immediately, and then turned that into a marketing piece that sets us apart from the competition and has served as a terrific door-opener.”

Year after year, Tager gets us amazing media results. Their writing is impeccable and almost instantaneous. They’re not just super responsive to our requests, they’re a strategic thought partner always delivering innovative ideas.”

Tager&Co.’s ability to understand and communicate our products and services helped us broaden our target markets.”

The week we announced the launch of our company, Dave got us a cover story in the Boston Globe, a CBS segment, an article in Seattle Times, and coverage in all our key biopharma trades. … From my past experience with the Tager team, this wasn’t a surprise. They always get the best results.”